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Preterm delivery – etiopathogenesis 
and treatment
Poród przedwczesny – etiopatogeneza i leczenie
ABSTRACT
Preterm delivery is a delivery after 22 and before 37 weeks gestation. The incidence 
of preterm delivery is very diverse from 5% in European countries to 18% in Africa.
The etiopathogenesis of preterm delivery is multifactorial and still not fully under-
stood. The article presents factors related to the increased risk of preterm delivery and 
possible methods of treatment to prevent the occurrence of preterm delivery. It also 
present obstetric behavior and treatment including patterns of tocolytic and gluco-
corticoid treatment taking into account recommendations.
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STRESZCZENIE
Poród przedwczesny to zakończenie ciąży po 22., a przed 37. tygodniem ciąży. Częstość 
występowania porodów przedwczesnych jest bardzo zróżnicowana od 5% w krajach 
europejskich do 18% w Afryce. Etiopatogeneza przedwczesnego ukończenia ciąży 
jest wieloczynnikowa i nadal nie w pełni poznana. W pracy omówiono czynniki zwią-
zane ze wzrostem ryzyka porodu przedwczesnego oraz możliwe metody postępo-
wania w celu zapobiegania występowania porodu przedwczesnego. Przedstawiono 
postępowanie położnicze i leczenie z uwzględnieniem schematów stosowania leków 
tokolitycznych oraz glikokortykosteroidów zgodnie z obecnymi rekomendacjami.
Słowa kluczowe: poród przedwczesny, czynniki ryzyka, leczenie tokolityczne, toko-
lityki
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Introduction
According to the defi nition of the World 
Health Organization (WHO), Preterm Birth 
(PTB) includes any birth occurring after 22 
weeks (154 days) of gestation, and before 37 
completed weeks (259 days) of gestation (Ka-
linka, Bitner, 2012; Podsiadło, 2014).
In clinical practice, the classifi cation creat-
ed by Czajka (Czajka, 1994) seems to be the 
most important, and it distinguishes:
A. Threatened Preterm Labour includes the 
early phase of labour that can be stopped. 
It is characterized by the presence of uter-
ine muscle contraction activity, with no 
changes in the cervix.
B. Preterm Labour refers to the advanced 
stage of labour, diffi  cult to be slowed 
down. It is characterized by a regular and 
increasing uterine contractile function 
with simultaneous progressive cervical 
dilatation.
C. Preterm Birth refers to the birth of a new-
born before 37 weeks of gestation.
Another classifi cation considers the week 
of pregnancy in which preterm labour took 
place and divides it into:
A. Extremely Preterm Labour – before 28 
weeks of gestation.
B. Very Preterm Labour – completed before 
32 weeks of gestation.
C. Moderately Preterm Labour – between 33 
and 36 weeks of gestation.
The purpose of the article
The aim of the study was to present factors 
infl uencing the increased risk of preterm de-
livery as well as methods of treatment aimed 
at preventing preterm delivery. In addition, 
the methods of obstetric and therapeutic 
management are discussed, including the 
patterns of tocolytic and glucocorticoid treat-
ment taking into account recommendations.
Epidemiology
Annually, approximately 15 million children 
are born prematurely. Preterm birth rates vary 
widely from 5% in European countries to 18% 
in the sub-Saharan Africa (and largely depend 
on the world region). The largest percent-
age, as much as 60% of all preterm births, is 
recorded in poor parts of the world, such as 
Africa or the countries of South Asia. Based on 
data from European countries, the incidence 
of preterm labours is estimated at 5.5–11.1%. 
Finland and Ireland are the countries with 
the least preterm birth rate of 4.3%, while the 
country with the highest rate is Austria – 8.7%. 
In Poland, the preterm birth percentage was 
changing over the last several years from 6.8% 
recorded in 1996, followed by a slight de-
crease to 6.3% in 2000, and a further increase 
in 2012 to 6.8%. Currently, in our country, the 
rate of preterm labours is 7%. On the other 
hand, the number of births before 32 weeks 
of gestation signifi cantly decreased and now 
they constitute 0.95% of all births (Wielgoś, 
2016).
Reasons and risk factors of preterm 
labour
Preterm delivery is a clinical condition that 
is aff ected by many factors. Clinical practice 
comprises a division of preterm labours based 
on their reasons, in which the following are 
distinguished (Kalinka, Bitner, 2012; Pod-
siadło, 2014).
a) spontaneous uterine contractile function 
(idiopathic preterm labour) – 29–47% of 
pregnant women with diagnosed preterm 
labour;
b) premature rupture of membrane (PROM) 
– 23–38% of pregnant women; 
c) premature termination of pregnancy due 
to medical indications (iatrogenic preterm 
labour) – 21–37% of women (Kalinka, Bit-
ner, 2012; Podsiadło, 2014).
According to the classifi cation established 
by Chamberlain (1984), four main categories 
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of factors: medical, social, environmental, psy-
chogenic factors, predisposing to preterm de-
livery, are distinguished.
A. Medical factors:
 obstetric causes requiring labour induc-
tion or surgical termination of pregnan-
cy: preterm placental abruption, sus-
pected placental insuffi  ciency, placenta 
praevia, pregnancy-induced hyperten-
sion, intrauterine foetal growth retarda-
tion, serological confl ict;
 obstetrical causes leading to sponta-
neous uterine contractile function: pre-
term membrane rupture, congenital 
uterine anomalies, intrauterine infec-
tions, cervical incompetence, multiple 
pregnancies.
B. Social factors: low economic status, poor 
eating habits, inadequate care during 
pregnancy or its lack, use of stimulants, 
age of the woman (under 17 and over 35), 
multiparity and single marital status.
C. Environmental factors: 
 chemical factors: contact with the envi-
ronment contaminated with heavy met-
als, sulphur compounds or fl uorine;
 physical factors: electromagnetic fi eld, 
all types of radiation, vibrations, as well 
as noise.
D. Psychogenic factors: mental disorders 
present in the family, or in the pregnant 
woman, confl ict situations in the fami-
ly, poor fi nancial situation of the fami-
ly, stress associated with excess duties, 
eventful obstetric history, anxiety of the 
pregnant woman concerning her preg-
nancy and the child’s health status.
Genetic determinants may also be a risk 
factor for preterm labour, as shown by the re-
sults of studies. Porter et al (Kalinka, Bitner, 
2012) demonstrated that women who were 
born at 36 weeks have greater predispositions 
for preterm labour, and the odds ratio was 
1.18. However, in the case of women born be-
fore 30 weeks of gestation, this risk increases 
2.4 times (Kalinka, Bitner, 2012; Wielgoś, 2016).
Currently, the participation of polymor-
phisms of genes that are involved in the cas-
cade of processes leading to preterm labour is 
also considered. Particularly, genes encoding 
proinfl ammatory cytokines as well as tumour 
necrosis factor which regulate the intensifi ca-
tion of the infl ammatory response, are thor-
oughly analysed. These proteins are responsi-
ble for the synthesis of prostaglandins, as well 
as reduce the sensitivity of the uterus to pro-
gesterone, and thus signifi cantly increase the 
risk of premature contractile function (Wiel-
goś, 2016). 
Etiopathogenesis of preterm labour
The etiopathogenesis of preterm labour is 
multifactorial and not fully understood. Rob-
erto Romero et al (Wielgoś, 2016) created 
the term of preterm labour syndrome, which 
refl ects the complex pathogenesis and diver-
sity of risk factors aff ecting the probability of 
preterm birth. 
Disorders of vaginal biocenosis and intra-
uterine infections are considered one of the 
dominant causes of preterm labour. The oc-
currence of a reproductive tract infection dur-
ing pregnancy may trigger the arachidonic 
acid cascade and, as a result, lead to the syn-
thesis of prostaglandins and collagenases. 
These substances are responsible for the oc-
currence of uterine contractile function, as 
well as the maturation and shortening of the 
cervix. In addition, hydrolysis of collagen may 
occur in amniotic cells, which may result in 
membrane rupture (Wielgoś, 2016). 
Microorganisms penetrating into the am-
niotic cavity, cause the development of in-
traamniotic infection and the onset of foe-
tal infl ammatory syndrome. Microorganisms 
cause the activation of Toll-like Receptors 
(TLR), which connecting to the ligand lead to 
the activation of the nuclear factor. As a result 
of these changes, the mediators of infl amma-
tory response, such as: interleukin (IL) -1, -6, 
-8, -10, Tumor Necrosis Factor Alpha (TNF-α), 
are released by macrophages. Cells and in-
fl ammatory cytokines present in the amniotic 
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fl uid cause foetal lungs to release a surfactant, 
which has an inhibitory eff ect on the infl am-
matory response, and on the other hand leads 
to the induction of preterm labour. Studies 
demonstrate that 12% of women giving pre-
mature birth had symptoms of reproductive 
tract infections (Wielgoś, 2016; Leszczyńska, 
2006). 
Current research prove that abnormal im-
plantation, and thus disorders of uteroplacen-
tal perfusion also aff ect the increase in the 
probability of preterm labour. Animal studies 
confi rmed that ischemia of the uterine muscle 
aff ects triggering of contractile function. Ac-
cording to another theory, ischemia leads to 
the release of tissue factors that in turn stim-
ulate haemolytic and thrombotic processes. 
Extravasated blood and thrombin contained 
in it aff ect the production of proteases, which 
are responsible for cervical dilation, mem-
brane rupture, and initiation of contractile 
function (Kalinka, Birner, 2012; Wielgoś, 2016; 
Leszczyńska, 2006). 
Another theory assumes the eff ect of ex-
cessive stretching of the uterine muscle on 
the occurrence of premature contractile ac-
tivity. This is related to the increase in intrau-
terine pressure, which is relatively constant in 
physiological pregnancy and is balanced by 
progesterone or nitric oxide (NO). In the case 
of multiple pregnancies or polyhydramnios, 
excessive stretching of the uterus, increased 
production of prostaglandins (PG) and in-
creased number of oxytocin receptors occurs, 
which may ultimately lead to premature uter-
ine contractile activity (Kalinka, Birner, 2012; 
Leszczyńska, 2006).
The responses of the immune system re-
main important. Pregnancy can be consid-
ered a kind of “transplant”. Immunologists 
suggest that obstetric failures, such as mis-
carriage, premature labour, intrauterine foe-
tal growth retardation, may be caused by an 
abnormal response of the mother’s body to 
a foreign antigen, which is a foetus. In addi-
tion, immune system disorders, such as sys-
temic lupus erythematosus, or an antiphos-
pholipid syndrome predispose to preterm 
labour. This is because in aff ected pregnant 
women, they lead to pathological lesions in 
the placental vessels, and thus can lead to 
bleeding and subsequently to a preterm birth 
of the child. On the basis of research, Arias et 
al proved that immunological factors can be 
the cause of as much as 33% of preterm la-
bours (Wielgoś, 2016).
The last mechanism that can contribute to 
preterm labours is the neurohormonal mech-
anism. Progesterone is the hormone responsi-
ble for the correct course of implantation, |as 
well as the maintenance of pregnancy, by in-
hibiting the uterine contractile function and 
cervical maturation. The most common disor-
der associated with progesterone defi ciencies 
is luteal phase defect (LDP). Pregnant women 
with diagnosed LDP who do not take proges-
terone during pregnancy give birth prema-
turely in 31.2%. On the other hand, in wom-
en receiving progesterone, preterm labour af-
fects 13.7% of cases (Kalinka, Bitner, 2012).
Other hormones involved in the neuro-
hormonal mechanism are corticosteroids. In 
a physiological pregnancy, foetal corticos-
teroid levels increase in the perinatal period. 
However, in the case of excessive exposure 
to stress, an increase in the concentration of 
adrenocorticotropic hormones (ACTH) during 
pregnancy, and thus an increase in 11-β-hy-
droxylase in the foetal adrenal glands take 
place. The hydroxylase enzyme causes a pro-
duction of additional amounts of corticoster-
oids that aff ect the production of estriol. It is, 
in turn, a hormone responsible for the induc-
tion of labour with the participation of pros-
taglandins and oxytocin (Leszczyńska, 2006).
Previous studies have demonstrated that 
corticoliberins also contributes to the regula-
tion of the duration of pregnancy. Corticoli-
berin is synthesized both in the hypothalamus 
and placenta. From the 16th week of pregnan-
cy, its concentration gradually increases and 
the peak of production is in the perinatal pe-
riod. Studies show that an increase in its con-
centration between 16 and 20 weeks of preg-
nancy increases the probability of preterm la-
bour (Kalinka, Bitner, 2012; Wielgoś, 2016). 
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Diagnostics
Clinical diagnostic criteria for preterm labour 
include:
a) gestational age between 22+0 and 36+6 
weeks of gestation;
b) regular contractile activity of the uterine 
muscle (6 contractions/hour);
c) lesions in the cervix: 
 shortening by 80%;
 dilation ≥ 2 cm.
d) lower abdominal pain and losing mucus 
plug (Wielgoś, 2016).
If in a pregnant woman a suspicion of 
threatening preterm labour occurs, addition-
al tests are included in the diagnostics, such 
as biochemical preterm labour markers. These 
substances enable determination of the prob-
ability of premature birth (Wielgoś, 2016).
The fi rst marker used in the diagnosis is 
foetal fi bronectin (FFN). This extracellular gly-
coprotein is produced at the border of the 
amniotic and temporal bag, i.e. in the ma-
ternal-foetal interface. FFN is involved in the 
formation of connections between the foe-
tal membranes and the uterine mucosa. In 
physiological conditions high concentrations 
of foetal fi bronectin occur between 10th and 
12th weeks of gestation and indicate normal 
tissue development in the uteroplacental in-
terface, while from the 18th week of gestation 
its level should decrease below 0.05 μg/ml. Fi-
bronectin should be indeterminable between 
22 and 37 weeks of gestation. In this time in-
terval, an increase in FFN concentration above 
0.05 μg/ml indicates abnormalities in the ma-
ternal-foetal interface, and thus an increased 
probability of preterm labour. Each result is 
valid for 7–14 days and may be repeated if 
necessary (Kalinka, Bitner, 2012; Marszałek, 
Rychlik, et al, 2014).
Another indicator used to assess the risk 
of preterm delivery is the concentration of 
estriol (E3) in the saliva of a pregnant wom-
an. Estriol is the main estrogen in pregnancy 
and in about 90% originates from foetal and 
placental precursors. The estriol concentra-
tion gradually increases during the fi rst and 
second trimester of pregnancy, while in the 
third trimester it reaches the highest values. 
The production of this hormone takes place 
3–4 weeks before labour. Studies carried out 
by Hedrian et al demonstrate that the concen-
tration of estriol increases from 0.89 ng/ml de-
terminable in the 30th week of gestation to 
2.7 ng/ml at the labour time, with a rapid in-
crease in concentration observed in the 35th 
week. In addition, it was demonstrated that 
an increase in estriol value above 2.1 ng/ml in 
the 30th week of gestation is a predictive fac-
tor of preterm labour. However, it should be 
remembered that estriol is a hormone subject 
to variations in the diurnal cycle and reaches 
the highest concentrations at night, therefore 
it is recommended to conduct the test during 
the day, 30 minutes after a meal (Semczuk, 
Krzyżanowski, 2011). 
Phosphorylated insulin-like growth factor 
binding protein-1 (phIGFBP-1) is also a mark-
er used to assess the risk of preterm labour. It 
is produced by the decidua and regulated by 
progesterone. The highest concentrations of 
phIGFBP-1 are observed in the perinatal peri-
od as a result of separation of the foetal mem-
branes and the decidua. Values above 30μg/
ml determined in cervical secretion may indi-
cate an increased risk of preterm labour with-
in seven days after the performed measure-
ment. Studies demonstrate that an increase 
in the concentration of phIGFBP-1 correlates 
with an increased risk of labor (Kalinka, Bitner, 
2012; Semczuk, Krzyżanowski, 2011). 
Ultrasound (US) transvaginal cervical 
length measurement is a test used in clin-
ical practice to assess the risk of preterm la-
bour. During the test, the patient should have 
emptied the urinary bladder. The ultrasound 
head is placed in the front vaginal vault to ob-
tain a correct sagittal section. During the test, 
the external and internal orifi ce of the cervix 
as well as the mucosa of the canal should be 
identifi ed. The measurement must be per-
formed between the triangular area of the ex-
ternal orifi ce and the V-shaped recess of the 
internal orifi ce and repeated 2–3 times during 
the entire ultrasound examination. Studies 
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demonstrate that shortening of the cervix 
in the second trimester is a predictive factor 
of preterm labour. In the group of pregnant 
women with an increased risk of preterm la-
bour, ultrasound examination of the length 
of the cervix is recommended every 2 weeks 
between 14 and 22 weeks of gestation. The 
probability of preterm birth is inversely corre-
lated with the length of the cervix (Wielgoś, 
2016; Wielgoś, Szymusik, 2011). 
Other factors that can be used to assess 
the risk of preterm labour include: assessment 
of IL-6 in vaginal discharge and IL-8 in cervi-
cal secretion; pH assessment in vaginal dis-
charge; a nitrazine test; assessment of prol-
actin and α-fetoprotein concentration (Sem-
czuk, Krzyżanowski, 2011).
In summary, the diagnosis of preterm la-
bour should include: an accurate family histo-
ry to assess the risk of preterm labour, mon-
itoring of uterine contractile function, an as-
sessment of infections and invasions in the 
lower reproductive tract, an assessment of the 
condition of the cervix including ultrasound 
and biochemical tests, as well as an assess-
ment of the outfl ow of amniotic fl uid (Sem-
czuk, Krzyżanowski, 2011).
Prophylaxis of preterm labour
The etiopathogenesis of preterm delivery has 
not yet been fully understood, and moreo-
ver, the multiplicity of risk-increasing factors 
means that there is no eff ective method to 
prevent premature birth of a newborn. In the 
selection of appropriate obstetric procedure, 
both risk factors and probable pathogenic 
mechanisms should be considered (Wielgoś, 
2016).
One of the factors signifi cantly increasing 
the possibility of preterm labour includes dis-
orders of vaginal biocenosis and intrauterine 
infections. Studies demonstrate that the use 
of antibiotic therapy every 4 months until the 
conception in women whose history is bur-
dened with preterm labour does not bring the 
expected results (Wielgoś, 2016). In pregnant 
women suff ering from bacterial vaginosis 
during gestation, the introduction of clinda-
mycin therapy reduces the probability of late 
miscarriage, as well as labour before 37 weeks 
of gestation. However, the risk of labour be-
fore 33 weeks of gestation does not decrease 
despite the treatment (Wielgoś, Szymusik, 
2011). In the case of bacterial vaginosis, the 
use of clindamycin seems to be correct, as it 
has greater effi  cacy compared to metronida-
zole (Wielgoś, 2016). In case the microorgan-
isms colonise the cervix, the endometrium, as 
well as the decidua, the use of antibiotics in 
their intravaginal form, is not associated with 
risk reduction. 
In the prophylaxis of preterm labour oc-
curring as a result of genital infections, main-
taining the vaginal ecosystem seems to be 
very important. The main microorganisms of 
the vaginal ecosystem are lactobacilli, which 
hinder the development of pathogens. In ad-
dition to the use of probiotics of human ori-
gin, the diet of pregnant women seem to be 
important. It should abound in dairy products 
containing probiotics, as well as garlic or dried 
fruits, which are a natural source of prebiotics. 
Both probiotics and prebiotics increase the 
risk of preterm labour. However, these the-
ories are still at the research phase (Myhre, 
Brantsæte, et al, 2011; Myhre, Brantsæte, et al, 
2013).
Another factor aff ecting the probability 
of preterm labour is premature opening and 
shortening of the cervix. Currently, in the area 
of prophylaxis, progesterone, cervical cer-
clage or cervical pessary are used (Wielgoś, 
2016; Milanowska-Koloch, 2014).
Progesterone is a hormone that inhibits 
premature cervical dilation. Studies demon-
strate that progesterone administered intra-
vaginally at a dose of 250  mg/week in preg-
nant women with a cervix shortened below 
25 mm reduces the probability of preterm 
labour before 35 weeks of gestation (Bom-
ba-Opoń, 2012). In the case of women in 
whom shortening of the cervix below 15 
mm occurs, the progesterone application 
does not reduce the risk of preterm labour. 
The team of experts of the Polish Society of 
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Gynecologists and Obstetricians (PTG) rec-
ommends the intravaginal administration of 
progesterone in pregnant women with short-
ened cervix, or with eventful obstetric history 
(Bomba-Opoń, 2012). In 2008, the ACOG rec-
ommended a prophylactic administration of 
progesterone in women with obstetric history 
in the direction of preterm labour. In turn, the 
Food and Drug Administration (FDA) in 2011 
issued recommendations according to which 
it is recommended to use 17-α-hydroxypro-
gesterone in women with a history of pre-
term labour, and the supplementation should 
start between 16 and 21 weeks of gestation. 
Prophylactic use of progesterone in multiple 
pregnancies unfortunately does not bring the 
expected results (Bomba-Opoń, 2012).
Cervical cerclage is one of the oldest meth-
ods of treatment of cervical incompetence and 
is based on performing McDonald, Shirodkar 
circular cerclage or abdominal cerclage. This 
method is performed under general anaes-
thesia and is associated with the possibility of 
complications such as premature rupture of 
membrane, intraoperative cervical injury, in-
trauterine infection, cerclage slippage from 
the cervix, as well as bleeding from the repro-
ductive tract. Performing a cervical cerclage 
with cervix shortening below 25 mm con-
fi rmed by an ultrasound examination reduc-
es the percentage of preterm births and thus 
improves neonatal results. The use of a res-
cue cerclage, which is performed before 24 
weeks of gestation in pregnant women with 
a dilation of not less than 4 cm, in the absence 
of contractile activity of the uterine muscle, 
improves obstetric and neonatal results (Wiel-
goś, 2016; Milanowska-Koloch, 2014).
The cervical pessary is intended to sup-
port the cervix by directing the cervix towards 
the sacrum and thereby relieving the inter-
nal orifi ce. The cervix is placed in the central 
opening of the pessary. They are made of fl ex-
ible silicone. Despite this, women may expe-
rience increased discharge and discomfort. 
Therefore, currently they are not recommend-
ed in prophylaxis of preterm labour (Wielgoś, 
2016; Milanowska-Koloch, 2014). 
Incorrect implantation can also aff ect the 
occurrence of preterm labour. This condition 
may lead to preeclampsia, premature sepa-
ration of the placenta, or intrauterine foetal 
growth restriction. These pathologies are in-
dications for iatrogenic preterm termination 
of pregnancy (Wielgoś, 2016). The introduc-
tion of prophylaxis during the development 
of uteroplacental circulation and spiral artery 
formation may signifi cantly reduce the risk 
of the onset of obstetric complications in the 
second half of pregnancy (Wielgoś, 2016). The 
introduction of acetylsalicylic acid in preg-
nant women with an eventful history, as well 
as anomalies in the uterine arteries, reduc-
es the risk of preeclampsia and, consequent-
ly, preterm labour. It is important to include 
the prophylaxis before 16 weeks of gesta-
tion, before the end of formation of the walls 
of spiral arteries (Bujold, Roberge, et al, 2010). 
Products with acetylsalicylic acid should 
be taken in the evening, and the daily dose 
should be within 50–100 mg. Low molecular 
weight heparin is a substance that is admin-
istered to pregnant women with thrombo-
philia. Recent studies using heparin togeth-
er with acetylsalicylic acid as prophylaxis for 
preeclampsia in pregnant women not suff er-
ing from thrombophilia have demonstrated 
a signifi cant improvement in obstetric out-
comes (Wielgoś, 2016).
Obstetric procedures and treatment 
The main goal of therapeutic procedure in 
preterm labour is to minimize the mortality 
and morbidity of newborns born premature-
ly. Research proves that spontaneous uterine 
contractile function precedes about 40–45% 
of preterm labours. The introduction of tocol-
ysis intended to suppress the contractile func-
tion and delay preterm labour is of signifi cant 
importance for the newborn (Wielgoś, 2016; 
Poniedziałek-Czajkowska, Mierzyński, et al, 
2013). It enables implementation of the fol-
lowing activities: 
a) providing the woman with a place in the 
tertiary referral hospital;
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b) administration of corticosteroids to accel-
erate foetal lung development;
c) administration of magnesium sulphate 
before 32 weeks of gestation, in order to 
reduce the risk of cerebral palsy;
d) application of antibiotic therapy as proph-
ylaxis of infection with group B strepto-
cocci (GBS).
Acute tocolysis should be introduced 
from the lower limit of neonatal survival to 
34+6 weeks of gestation and be conduct-
ed for 48 to 72 hours. Extending the thera-
py does not seem to be justifi ed because it 
does not reduce the prevalence of preterm 
Table 1. Contraindications to the introduction of tocolysis (Poniedziałek-Czajkowska, Mierzyński, et 
al, 2013).
Maternal contraindications Foetal contraindications
 severe hypertension
 bleeding from the reproductive tract
 heart disease with impaired cardiovascular function
 medical and obstetric contraindications
 bad tolerance of medication used for tocolysis
 cervical dilation to 4–5 cm
 shortening of the cervix
 gestational age over 34 weeks
 intraamniotic infection
 intrauterine foetal death
 lethal defects in the foetus
 foetal life-threatening symptoms: hypoxia, intrauterine growth re-
striction
Table 2. Characteristics of medications used in tololysis (Wielgoś, 2016; Poniedziałek-Czajkowska, 
Mierzyński, et al, 2013).
Medication Description
Calcium antagonists – 
nifedipine
 shows great eff ectiveness
 only oral form
 higher safety of use compared to β-mimetics
 cannot be combined with β-mimetics and magnesium sulphate
Β-mimetics
– fenoterol
 shows great eff ectiveness
 intravenous form
 numerous contraindications considering health condition of the pregnant woman
 need for intensive monitoring of the pregnant woman and the foetus
 occurrence of side eff ects in both the mother and the foetus
 they must not be combined with calcium antagonists, as vascular complications may occur
COX inhibitor
– indometacin
 is eff ective and despite this it is rarely used
 it can only be administered before 32 weeks of gestation
 requires intensive monitoring of well-being of the foetus (AFI assessment, Doppler fl ow study)
Oxytocin antagonist 
– atosiban
 shows great eff ectiveness as well as safety of use from 24 weeks of gestation
 form of intravenous infusion
 no contraindications related to the mother
 slight side eff ects of use
 this medication can be combined with magnesium sulphate administered for neuroprotective 
purposes
 high cost of treatment
birth. Contraindications to the referral for toc-
olysis are presented in Table 1 (Wielgoś, 2016; 
Poniedziałek-Czajkowska, Mierzyński, et al, 
2013).
Nowadays, medications such as calcium 
channel blockers, β-mimetics, cyclooxygen-
ase (COX) inhibitors, oxytocin receptor antag-
onists are recommended for the treatment 
of preterm labour (Table 2). In Poland, the 
most commonly introduced medications in-
clude fenoterol as a representative of β-mi-
metics or nifedipine, which is a calcium recep-
tor antagonist (Wielgoś, 2016; Ponie działek-
Czajkowska, Mierzyński, et al, 2013). 
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Nifedipine has an inhibitory eff ect on the 
infl ow of Ca2+ ions to the inside of smooth 
muscle cells, which results in their relaxation. 
There are two oral dosage regimens:
1. Administration of 6  10 mg or 4  10 mg 
within 20 minutes, after 4 hours 6  20 mg 
for 48 hours, and subsequently 3  10 mg.
2. Administration of the initial dose equal to 
20 mg, then 10–20 mg every 6 to 8 hours 
for 48 hours.
During the administration of tokolysis ac-
cording to the above regimen, it is necessary 
to monitor the health condition of the moth-
er: blood pressure, heart rate and tempera-
ture, as well as the well-being of the foetus. 
Nifedipine reaches maximum concentrations 
in the blood within 15–90 minutes after ad-
ministration. The above medication cannot be 
combined with β-mimetics and administered 
sublingually (Poniedziałek-Czajkowska, Mie-
rzyński, et al, 2013; Czajka, 2008).
The use of β-mimetics allows the post-
ponement of preterm labour, however, it 
causes many adverse reactions both in the 
mother and in the foetus. Side eff ects result 
from non-selective stimulation of all receptors 
that induce muscle relaxation. In a pregnant 
woman, they can lead to: tachycardia, dysp-
nea, palpitations, an increase in blood glucose 
concentration above 180 mg/dl or a decrease 
in potassium concentration below 2.5 mEq/l. 
Therefore, β-mimetics are contraindicated in 
women with heart disease, diabetes and hy-
perthyroidism. The introduction of tocolysis is 
recommended between the 22 and 37 weeks 
of gestation for 48 hours under the conditions 
of continuous monitoring of the health con-
dition of the mother and the child. The dos-
age regimen includes the administration of 
fenoterol by intravenous infusion from 1 mg to 
¾ mg per minute, and the initial dose should 
equal 3.5 mg/minute. After termination of the 
uterine contractile function, the minimum ef-
fective dose is set (Poniedziałek-Czajkowska, 
Mierzyński, et al, 2013; Czajka, 2008).
The action of nonsteroidal anti-infl amma-
tory drugs (NSAIDs) is based on the inhibition
of cyclooxygenase (COX), which is involved in 
the synthesis of prostaglandin G
2
. The main 
representative of COX inhibitors is indometa-
cin. Restrictions in its use during preterm la-
bours result from its unfavourable eff ect on 
the condition of the newborn due to the 
blockage of constitutive COX (COX-1) in foe-
tal tissues. This medication cannot be admin-
istered after 32 weeks of gestation. According 
to the regimen, the initial dose is 50 mg ad-
ministered orally or rectally; the maintenance 
dose is 25-50 mg administered every 6 hours, 
while the daily dose cannot exceed 200 mg. 
Pharmacotherapy cannot last longer than 48 
hours. Both before the treatment, and after 
48 and 72 hours an ultrasound examination 
should be performed to assess the AFI (Wiel-
goś, 2016; Poniedziałek-Czajkowska, Mie rzyń-
ski, et al, 2013).
Oxytocin receptor antagonists, whose rep-
resentative is atosiban, eff ectively inhibit the 
uterine contractile function, as well as do not 
show signifi cant adverse reactions. However, 
it does not aff ect the improvement of obstet-
ric outcomes. Pharmacotherapy can be intro-
duced between 24 and 33 weeks of gestation 
and cannot exceed 48 hours. The total accept-
able dose is 330 mg. Initially, 6.75 mg is inject-
ed intravenously, after which a continuous 
infusion with a fl ow of 18 mg/hour is recom-
mended for 3 hours, and then the fl ow is re-
duced to 6 mg/hour for 45 minutes (Wielgoś, 
2016; Poniedziałek-Czajkowska, Mierzyński, et 
al, 2013).
Antibiotic therapy used in the case of 
threatening preterm labour is aimed at reduc-
ing perinatal infection of the newborn with 
group B streptococci in the case of confi rmed 
infection in the mother. In addition, the ACOG 
recommends the introduction of appropriate 
antibiotics in such cases as: PROM, bacteri-
al vaginosis or intrauterine infection (Ponied-
ziałek-Czajkowska, Mierzyński, et al, 2013).
Preterm labour always has to take place in 
highly specialized centres that are able to en-
sure the safety of the woman giving birth, as 
well as neonatal care to newborn babies born 
prematurely.
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Steroid therapy and neuroprotection 
In pregnant women with threatening pre-
term labour, the administration of glucocor-
ticosteroids is a vital element of a therapeu-
tic procedure. The introduction of the treat-
ment will signifi cantly reduce the probability 
of a infant respiratory distress syndrome, ne-
crotizing enterocolitis, intraventricular hem-
orrhage, and also reduces perinatal mortality. 
According to the PTG guidelines, pharmaco-
therapy should be introduced in case of any 
threatening preterm labour between24+0 
and 34+6 weeks of gestation, with no contrain-
dications. In addition, it is possible to repeat 
the therapy (the so-called rescue cycle of ster-
oid therapy) in pregnant women, whose fi rst 
treatment took place before 26 or 32 weeks of 
pregnancy with the probable completion of 
pregnancy within 7 days. There are two dos-
age regimens:
1. Betamethasone – 12 mg every 24 hours in 
2 doses administered intramuscularly.
2. Dexamethasone – 6 mg every 12 hours 
in 4 doses administered intramuscularly 
(Wielgoś, 2016; Poniedziałek-Czajkowska, 
Mierzyński, et al, 2013).
Preterm labour, as well as preterm birth 
are associated with an increased risk of neuro-
logical complications in the newborn. Nowa-
days, the use of magnesium sulphate (MgSO
4
) 
as a medication showing tocolytic activity is 
minimal. However, the results of the studies 
demonstrate that it has a protective eff ect 
on the central nervous system of a prema-
ture baby, and thus signifi cantly reduces the 
occurrence of infantile cerebral palsy and re-
duces the probability of motor defi cits. The 
pharmacotherapy regimen assumes the in-
travenous administration of the initial dose in 
the form of 4 g of MgSO
4
 for 20 to 30 minutes, 
and then the administration of 1 g/hour in the 
form of intravenous infusion as a maintenance 
dose for up to 24 hours. Labour should nev-
er be delayed to administer magnesium sul-
phate therapy when any maternal or foetal in-
dications to complete pregnancy are present 
(Wielgoś, 2016; Poniedziałek-Czajkowska, Mi-
erzyński, et al, 2013).
In summary, despite the extensive knowl-
edge on aetiology, diagnosis, prevention and 
treatment, the problem of premature deliv-
ery remains valid and not fully explained. Cur-
rently, the main focus is on the elimination of 
risk factors for preterm delivery, with the use 
of methods to prevent pregnant women pre-
senting the fi rst symptoms of preterm deliv-
ery. Tocolithic treatment is limited to short-
term therapy in order to carry out a steroid 
therapy cycle, as well as providing proper care 
to both mother and child.
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